CN114617936A - Medicinal and edible five-refined-pressure-tablet candy capable of expelling toxoplasma gondii and preparation method thereof - Google Patents
Medicinal and edible five-refined-pressure-tablet candy capable of expelling toxoplasma gondii and preparation method thereof Download PDFInfo
- Publication number
- CN114617936A CN114617936A CN202210287626.XA CN202210287626A CN114617936A CN 114617936 A CN114617936 A CN 114617936A CN 202210287626 A CN202210287626 A CN 202210287626A CN 114617936 A CN114617936 A CN 114617936A
- Authority
- CN
- China
- Prior art keywords
- parts
- toxoplasma gondii
- medicinal
- expelling
- edible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000223997 Toxoplasma gondii Species 0.000 title claims abstract description 43
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 230000000694 effects Effects 0.000 claims abstract description 24
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 18
- 235000008434 ginseng Nutrition 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 18
- 241000383638 Allium nigrum Species 0.000 claims abstract description 16
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 14
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 14
- 235000015463 Lycium carolinianum Nutrition 0.000 claims abstract description 14
- 241000223996 Toxoplasma Species 0.000 claims abstract description 14
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 13
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 13
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 13
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 13
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 13
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 13
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 13
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 13
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 13
- 244000234609 Portulaca oleracea Species 0.000 claims abstract description 13
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 13
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 12
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 12
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 12
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 12
- 235000011477 liquorice Nutrition 0.000 claims abstract description 12
- 244000274050 Platycodon grandiflorum Species 0.000 claims abstract 4
- 239000003814 drug Substances 0.000 claims description 19
- 239000000463 material Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 12
- 241000245665 Taraxacum Species 0.000 claims description 11
- 210000004027 cell Anatomy 0.000 claims description 11
- 241001523681 Dendrobium Species 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 239000011259 mixed solution Substances 0.000 claims description 9
- 210000002421 cell wall Anatomy 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 241000208340 Araliaceae Species 0.000 claims 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 5
- 239000002775 capsule Substances 0.000 abstract description 3
- 230000001902 propagating effect Effects 0.000 abstract description 3
- 240000001949 Taraxacum officinale Species 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 description 13
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 12
- 208000015181 infectious disease Diseases 0.000 description 12
- 206010037660 Pyrexia Diseases 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 9
- 240000003582 Platycodon grandiflorus Species 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 7
- 231100000331 toxic Toxicity 0.000 description 7
- 230000002588 toxic effect Effects 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 239000002689 soil Substances 0.000 description 6
- 241000222336 Ganoderma Species 0.000 description 5
- 206010057179 Toxoplasma infections Diseases 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 206010016256 fatigue Diseases 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 208000004998 Abdominal Pain Diseases 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 206010036067 polydipsia Diseases 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 206010011732 Cyst Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 208000031513 cyst Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 230000035931 haemagglutination Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 210000003812 trophozoite Anatomy 0.000 description 3
- 208000000044 Amnesia Diseases 0.000 description 2
- 208000031091 Amnestic disease Diseases 0.000 description 2
- 206010009866 Cold sweat Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 244000241872 Lycium chinense Species 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 201000005485 Toxoplasmosis Diseases 0.000 description 2
- 230000006986 amnesia Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 244000000056 intracellular parasite Species 0.000 description 2
- 230000007102 metabolic function Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- ACTOXUHEUCPTEW-BWHGAVFKSA-N 2-[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2s,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-BWHGAVFKSA-N 0.000 description 1
- 208000000197 Acute Cholecystitis Diseases 0.000 description 1
- 241000605445 Anemarrhena asphodeloides Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008614 Cholecystitis acute Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003286 Protein-Energy Malnutrition Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010038776 Retching Diseases 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 239000004187 Spiramycin Substances 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001938 anti-toxoplasmal effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
- 229960004099 azithromycin Drugs 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000004313 glare Effects 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 206010026820 marasmus Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000024121 nodulation Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- WKSAUQYGYAYLPV-UHFFFAOYSA-N pyrimethamine Chemical compound CCC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C=C1 WKSAUQYGYAYLPV-UHFFFAOYSA-N 0.000 description 1
- 229960000611 pyrimethamine Drugs 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 229960001294 spiramycin Drugs 0.000 description 1
- 229930191512 spiramycin Natural products 0.000 description 1
- 235000019372 spiramycin Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004306 sulfadiazine Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/50—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by shape, structure or physical form, e.g. products with supported structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicinal and edible five-essence pressed candy for expelling toxoplasma and a preparation method thereof, and the medicinal and edible five-essence pressed candy is characterized by being prepared from the following raw materials in parts by weight: 30-40 parts of fructo-oligosaccharide, 18-20 parts of rhizoma polygonati, 3-5 parts of ginseng, 10-12 parts of boxthorn leaves, 6-8 parts of Chinese yam, 3-5 parts of dendrobe, 3-5 parts of honeysuckle, 3-5 parts of dandelion, 3-5 parts of liquorice, 3-5 parts of purslane, 3-5 parts of black garlic, 3-5 parts of angelica dahurica and 3-5 parts of platycodon grandiflorum; the invention has the advantages that: after the tablet candy for inhibiting and expelling toxoplasma gondii and toxoplasma gondii capsules is taken, the propagation activity of the toxoplasma gondii can be effectively inhibited, the toxoplasma gondii can be killed from a human body, and the toxoplasma gondii can be prevented from propagating in the human body.
Description
Technical Field
The invention relates to the technical field of functional food addition, in particular to medicinal and edible five-essence pressed candy capable of expelling toxoplasma and a preparation method thereof.
Background
Toxoplasma Gondii (Toxoplasma Gondii) is called as three-corpse worm in traditional Chinese medicine, is an animal-derived parasite spread disease, and intracellular parasites flow along with blood and reach all parts of the body to damage the brain, the heart and the eyeground, so that the immunity of people is reduced and various diseases are suffered. Mammals are main infectious sources, are closely contacted with animals, can be infected by using raw meat, raw milk, lettuce and the like, women in gestation period are very easy to be infected, most of infected women have no obvious symptoms, and part of infected women can have mild symptoms of atypical cold, such as fever, fatigue, muscular soreness and the like, and infected women can pass through a placenta to be transmitted to a fetus to cause abortion, dead fetus or malformation, and for example, children and adults also have the risk of myocarditis, encephalitis and brain softening.
It is an obligate intracellular parasite of the order coccidioideae, isosporozoa, genus toxoplasma. Its existence has been confirmed by scholars and professional organizations at home and abroad. Human and animal toxoplasma infections are widely distributed around the world, with adult infection rates of about 16-40 parts by weight, and some up to 70 parts by weight, in English and American surveys, 50-80 parts by weight, and up to 90 parts by weight for French people in continental Europe and Latin America.
The Toxoplasma gondii is infected by 25-50 weight parts, Chinese positive infection rate is 5-20 weight parts, and partial area is as high as 30 weight parts. With the increase of domestic pets, the positive infection rate is increasing dramatically. The infection of the human body has great influence and hidden danger on the health of the human body. According to the modern medical research, the anti-toxoplasma antibody detection is carried out in five items of prenatal examination before marriage, but the traditional medicine in the aspect of clinical treatment at present is the combined application of pyrimethamine and sulfadiazine, the treatment mechanism mainly comprises the inhibition of trophozoite and the control of clinical symptoms, but the traditional medicine has no effect on the cyst of toxoplasma, is easy to relapse, has long treatment period and has great side effect; antibiotic medicines such as spiramycin, clindamycin and azithromycin can be used for treatment, but the medicines have certain toxic and side effects, are required to be treated according to medical advice, are not suitable in life, and cannot solve toxoplasma infection in most of human bodies. Based on its characteristics (extremely high and extremely low temperature below can kill), there is no way to effectively kill toxoplasma gondii living bodies in the human body.
Disclosure of Invention
In view of the above problems, the present invention aims to provide a medicinal and edible five-essential oil tablet candy for expelling toxoplasma gondii and a preparation method thereof, wherein the medicinal and edible five-essential oil tablet candy is used for preparing food with a medicinal and edible food additive formula, and the activity of toxoplasma gondii is reduced by inhibiting trophozoite, so that toxoplasma gondii is expelled from cells, and then the toxoplasma gondii is expelled from human bodies in a way of being discharged from the human bodies through the own metabolic functions of the human bodies, thereby solving various problems caused by the infection of toxoplasma gondii in general people and overcoming the defects of the prior art.
The invention provides a medicinal and edible five-essence tabletted candy for expelling toxoplasma gondii, which is prepared from the following raw materials in parts by weight: 30 parts of fructo-oligosaccharide, 18-20 parts of sealwort (essence of glossy ganoderma), 3-5 parts of ginseng, 10-12 parts of boxthorn leaf (Chinese wolfberry herb), 6-8 parts of Chinese yam (essence of soil), 3-5 parts of dendrobium (mountain essence), 3-5 parts of honeysuckle, 3-5 parts of dandelion, 3-5 parts of liquorice, 3-5 parts of purslane, 3-5 parts of black garlic, 3-5 parts of angelica dahurica and 3-5 parts of platycodon grandiflorum.
The invention is preferably prepared from the following raw materials in parts by weight: 31 parts of fructo-oligosaccharide, 19 parts of rhizoma polygonati (essence of glossy ganoderma), 4 parts of ginseng, 11 parts of boxthorn leaves (Tianjing grass), 7 parts of Chinese yam (essence of soil), 4 parts of dendrobium (mountain essence), 4 parts of honeysuckle, 4 parts of dandelion, 4 parts of liquorice, 4 parts of purslane, 4 parts of black garlic, 4 parts of angelica dahurica and 4 parts of platycodon grandiflorum.
The invention also aims to provide a preparation method of the medicinal and edible five-essence tabletted candy for expelling toxoplasma gondii, which specifically comprises the following steps:
step S1: selecting raw materials, namely selecting rhizoma polygonati, ginseng, boxthorn leaves, Chinese yam, dendrobium, honeysuckle, dandelion, liquorice, purslane, black garlic, angelica dahurica and platycodon grandiflorum for preparing the five-essence tablet candy; wherein rhizoma Polygonati, Lycii folium, rhizoma Dioscoreae, herba Dendrobii, flos Lonicerae, herba Taraxaci, Glycyrrhrizae radix, herba Portulacae, black Bulbus Allii, radix Angelicae Dahuricae, and radix Platycodi are all refined decoction pieces, and are processed in the same year and strictly according to decoction piece standard, and Ginseng radix is artificially planted for more than five years;
step S2: ultrasonic cell wall breaking, ultrasonic cell crusher utilizes the dispersion effect of ultrasonic wave in liquid, makes liquid produce the effect of cavitation to make solid particle or cell tissue in the liquid break. Putting the cleaned Chinese medicinal herb refined decoction pieces into an ultrasonic cell pulverizer with power of 40KHZ of 1200W, and adding water 2; breaking cell wall at 40 deg.C for 4 min according to the proportion of medicine 1;
step S3: supercritical extraction, namely putting the raw materials prepared in the step S2 into SEF production equipment, taking CO2 as an extracting agent, producing the raw materials in an environment at the temperature lower than 25 ℃, fully dissolving the traditional Chinese medicinal materials by utilizing the relation between the dissolving capacity and the density of a supercritical fluid, and controlling the pressure range to obtain a mixed solution with the optimal proportion; then, the extracted substances are completely or basically precipitated by methods such as decompression and the like, impurities and ineffective components are removed in the process, and a high-concentration mixed solution is generated;
step S4: granulating, namely boiling and granulating the high-concentration mixed solution obtained in the step S3 by using fructo-oligosaccharide as a base material;
step S5: and (6) tabletting and forming.
The invention mainly solves the problems that:
1 at present, the effective rate of all medicinal and edible toxoplasma gondii repellents is mostly about 40 parts by weight, and the effective rate can be doubled by combining the ginseng of the invention with the boxthorn leaves and the black garlic, thereby fundamentally solving the difficult problem of repelling insects.
2. The toxoplasma gondii is used for improving immunity, and the utilization rate of all existing toxoplasma gondii products does not exceed 30 parts by weight of the absorption rate, so that the expected effect of improving immunity and further realizing toxoplasma gondii expelling cannot be achieved.
The invention utilizes continuous supplement and supplementation of homology of medicine and food to form bidirectional synchronous dynamic balance, and realizes good effect of expelling toxoplasma gondii.
The invention has the advantages and positive effects that:
1. after the tablet candy for inhibiting and expelling toxoplasma gondii and toxoplasma gondii capsules is taken, the propagation activity of the toxoplasma gondii can be effectively inhibited, the toxoplasma gondii can be killed from a human body, and the toxoplasma gondii can be prevented from propagating in the human body.
2. The invention selects pure traditional Chinese medicines as raw materials, selects proper proportion, realizes balanced collocation of the medicinal materials and has no side effect; the preparation method of the invention improves the effectiveness of the medicine under the condition of keeping the medicinal materials as far as possible from being damaged.
3. By eating the food added with the formula, the nutrition body and the cyst are removed effectively, the function of a human body is improved, the immune system damaged by the toxoplasma infection is repaired, and finally, the diseases caused by the toxoplasma infection are got rid of through the self regulation of the human body.
Detailed Description
In the following description, for purposes of explanation, numerous specific details are set forth in order to provide a thorough understanding of one or more embodiments. It may be evident, however, that such embodiment(s) may be practiced without these specific details. In other instances, well-known structures and devices are shown in block diagram form in order to facilitate describing one or more embodiments.
Example 1
The medicinal and edible five-essence tabletted candy for expelling toxoplasma gondii provided by the embodiment is prepared from the following raw materials in parts by weight: 31 parts of fructo-oligosaccharide, 19 parts of rhizoma polygonati (essence of glossy ganoderma), 4 parts of ginseng, 11 parts of boxthorn leaves (Tianjing grass), 7 parts of Chinese yam (essence of soil), 4 parts of dendrobium (mountain essence), 4 parts of honeysuckle, 4 parts of dandelion, 4 parts of liquorice, 4 parts of purslane, 4 parts of black garlic, 4 parts of angelica dahurica and 4 parts of platycodon grandiflorum.
Example 2
The medicinal and edible five-essence tabletted candy for expelling toxoplasma gondii provided by the embodiment is prepared from the following raw materials in parts by weight: 30 parts of fructo-oligosaccharide, 20 parts of sealwort (essence of glossy ganoderma), 3 parts of ginseng, 12 parts of boxthorn leaves (Tianjing grass), 8 parts of Chinese yam (essence of soil), 3 parts of dendrobium (mountain essence), 3 parts of honeysuckle, 5 parts of dandelion, 5 parts of liquorice, 3 parts of purslane, 5 parts of black garlic, 3 parts of angelica dahurica and 5 parts of platycodon grandiflorum.
Example 3
The medicinal and edible five-essence tabletted candy for expelling toxoplasma gondii provided by the embodiment is prepared from the following raw materials in parts by weight: 30 parts of fructo-oligosaccharide, 18 parts of rhizoma polygonati (essence of glossy ganoderma), 5 parts of ginseng, 10 parts of boxthorn leaves (Tianjing grass), 8 parts of Chinese yam (essence of soil), 4 parts of dendrobe (mountain essence), 5 parts of honeysuckle, 4 parts of dandelion, 4 parts of liquorice, 4 parts of purslane, 3 parts of black garlic, 5 parts of angelica dahurica and 3 parts of platycodon grandiflorum.
The application mainly aims at the problems that the toxoplasma gondii is treated by western medicines at present, has large toxic and side effects, is always treated due to side effects in the treatment process, influences the treatment effect and simultaneously generates drug resistance. These drugs can inhibit toxoplasma trophozoite, have no effect on cyst, and if used for a long time, generate drug toxicity, thus failing to achieve the purpose of curing toxoplasma. Through the formulation and research of the traditional prescription, the medicinal and edible food additive formula for expelling the toxoplasma is provided, the food with the medicinal and edible food additive formula prepared by the method is independently eaten, the activity of the toxoplasma is reduced by inhibiting a trophosome by utilizing the habit of the toxoplasma, the toxoplasma is expelled from cells, and then the toxoplasma is expelled from human bodies in a way of discharging the toxoplasma from the human bodies through the metabolic function of the human bodies, so that various problems caused by the infection of the toxoplasma by general people are solved, and the actual use requirement is met.
The coordination and complementarity among the components of the invention are as follows: the five-essence tablet candy is formed by mutually coordinating and complementing rhizoma polygonati, ginseng, boxthorn leaves, Chinese yam, dendrobium, honeysuckle, dandelion, liquorice, purslane, black garlic, angelica dahurica and platycodon grandiflorum and matching with fructo oligosaccharide.
The pharmacological drug properties of the medicinal materials are as follows:
sealwort (essence of sesame): sweet in flavor and neutral in nature. It enters spleen, lung and kidney meridians. Has effects in invigorating qi, nourishing yin, invigorating spleen, moistening lung, and invigorating kidney. Can be used for treating deficiency of spleen-stomach qi, asthenia, stomach yin deficiency, xerostomia, cough with little appetite, lung deficiency, cough with excessive consumption, hemoptysis, essence and blood deficiency, soreness of waist and knees, premature gray hair, and internal heat with thirst quenching effect.
Ginseng: warm in nature, sweet, slightly bitter and slightly warm in taste. It enters spleen and lung meridians. 1. Tonifying primordial qi is suitable for collapse of primordial qi. a. Exhaustion due to qi deficiency, marked by pale complexion, palpitation, restlessness, profuse sweating, and faint pulse. b. Qi collapse and exhaustion of yang, the upper symptoms are cold sweats and cold sweats, and the limbs are not warm. It is often combined with Fu Zi. 2, tonifying spleen and lung, it can treat spleen and lung qi deficiency. a. Weakness of the spleen and stomach, poor appetite, loose stool, lassitude, weakness, vomiting, diarrhea, pale tongue and slow pulse. b. Lung qi deficiency, cough and dyspnea with debilitation, movement with debilitation, spontaneous sweating with deficient pulse, and susceptibility to wind-cold. 3, produce fluid to quench thirst, it is indicated for thirst due to body fluid consumption and diabetes. a. It is often combined with Shi Gao and Zhi mu in treating thirst due to consumption of body fluid, qi and yin deficiency due to heat, polydipsia due to fever, sweating, fatigue, and large and weak pulse. b. Internal heat, diabetes, polydipsia, rapid pulse and weakness, which is caused by internal heat and deficiency of qi and yin. It is often combined with yin-nourishing and heat-clearing herbs. 4, tranquilizing mind and improving intelligence, it is indicated for restlessness, insomnia and amnesia caused by deficiency of qi and blood, and often combined with heart-nourishing and tranquilizing herbs. In addition, it is indicated for impotence due to blood deficiency and exuberance of healthy qi due to qi-hyperactivity and blood generation, self-strengthening of qi-hyperactivity and yang-qi, and strengthening healthy qi to eliminate pathogens.
Boxthorn leaf (chinese wolfberry herb): tonify liver and kidney, promote the production of body fluid to quench thirst, dispel wind and remove dampness, activate blood and resolve stasis. It is indicated for fever due to asthenia, polydipsia, conjunctival congestion, blurred vision, pain, nebula nyctalopia, metrorrhagia, leukorrhagia, sores and swelling due to heat-toxin.
Chinese yam (essence of soil): sweet, warm, mild and nontoxic. Mainly treats the diseases of impairment, deficiency, shortness of breath, cold and heat, evil qi removal, middle warmer tonifying, qi and strength benefiting, muscle growth and yin strengthening. It can be taken for a long time, and has effects of improving hearing and eyesight, reducing weight, and prolonging life. This meridian. Mainly treating head and face wandering wind, head wind and eye glare, descending qi, stopping lumbago, treating asthenia, marasmus, filling five internal organs, and removing dysphoria. And (6) recording. Tonify five strains and seven injuries, remove cold wind, calm heart spirit, tranquilize mind, tonify heart-qi deficiency, and open up heart holes for recording. And (6) screening. Strengthen tendons and bones, direct excretion of essence and amnesia. Daming. Replenishing kidney qi, strengthening spleen and stomach, stopping diarrhea, resolving phlegm and moistening skin and hair. Shizhen. The swelling and toxicity of raw pounded plaster can be dissipated. The process is Shaheng.
Dendrobe (mountain extract): mainly used for reinforcing stomach and promoting fluid production, nourishing yin and clearing heat. Can be used for treating yin deficiency and fluid deficiency, dry mouth, polydipsia, anorexia, retching, asthenic fever after disease, and dim and unclear vision.
Honeysuckle flower: sweet and cold in nature, entering lung and stomach meridians, and clearing away heat and toxic materials. It can be used for treating fever due to affection of exogenous wind-heat or epidemic febrile disease, heatstroke, toxic heat, dysentery, carbuncle, furuncle, pharyngitis, and various infectious diseases.
Dandelion: bitter and sweet, cold in nature, entering liver and stomach meridians, clearing away heat and toxic material, inducing diuresis and dissipating nodulation. It can be used for treating acute mastitis, lymphadenitis, lymphoid tuberculosis, furunculosis, acute conjunctivitis, common cold with fever, acute tonsillitis, acute bronchitis, gastritis, hepatitis, cholecystitis, and urinary tract infection.
Licorice root: sweet in taste and neutral in nature, and has the effects of invigorating spleen and replenishing qi, clearing away heat and toxic materials, eliminating phlegm and relieving cough, relieving spasm and pain, and harmonizing the medicines.
Purslane: sour and cold, entering liver and large intestine meridians, clearing away heat and toxic material, cooling blood and stopping bleeding, and stopping dysentery.
Black garlic: the powerful antioxidant effect of black garlic is the key reason for the good practical effect of black garlic on more symptoms. Enhancing the efficacy of the immune system and adjusting the blood sugar level with super-strong force.
Radix angelicae: pungent and warm in flavor, warm in nature, entering lung, spleen and stomach channels, relieving exterior syndrome and dispelling cold, dispelling pathogenic wind and relieving pain, dredging nasal orifice, eliminating dampness and stopping leukorrhagia, relieving swelling and pus, dispelling pathogenic wind and relieving itching.
Balloon flower: bitter and pungent in flavor, neutral in nature, entering lung meridian, dispersing lung qi, relieving sore throat, eliminating phlegm, and expelling pus.
The first, second and third formulas of the above embodiments have the same operation steps, and comprise the following steps:
step S1: selecting raw materials, namely selecting rhizoma polygonati, ginseng, boxthorn leaves, Chinese yam, dendrobium, honeysuckle, dandelion, liquorice, purslane, black garlic, angelica dahurica and platycodon grandiflorum for preparing the five-essence tablet candy; wherein rhizoma Polygonati, Lycii folium, rhizoma Dioscoreae, herba Dendrobii, flos Lonicerae, herba Taraxaci, Glycyrrhrizae radix, herba Portulacae, black Bulbus Allii, radix Angelicae Dahuricae, and radix Platycodi are refined decoction pieces, and processed according to the decoction piece standard in the same year, and Ginseng radix is artificially planted to obtain Ginseng radix with more than five years old;
step S2: ultrasonic cell wall breaking, ultrasonic cell crusher utilizes the dispersion effect of ultrasonic wave in liquid, makes liquid produce the effect of cavitation to make solid particle or cell tissue in the liquid break. Putting the cleaned Chinese medicinal herb refined decoction pieces into an ultrasonic cell pulverizer with power of 40KHZ of 1200W, and adding water 2; breaking cell wall at 40 deg.C for 4 min according to the proportion of medicine 1;
step S3: supercritical extraction, namely putting the raw materials prepared in the step S2 into SEF production equipment, taking CO2 as an extracting agent, producing the raw materials in an environment at the temperature lower than 25 ℃, fully dissolving the traditional Chinese medicinal materials by utilizing the relation between the dissolving capacity and the density of a supercritical fluid, and controlling the pressure range to obtain a mixed solution with the optimal proportion; then, the extracted substances are completely or basically precipitated by methods such as decompression and the like, impurities and ineffective components are removed in the process, and a high-concentration mixed solution is generated;
step S4: granulating, namely boiling and granulating the high-concentration mixed solution obtained in the step S3 by using fructo-oligosaccharide as a base material;
step S5: and (6) tabletting and forming.
The clinical effect comparison test report of the invention:
first, diagnosis standard
According to the modern medicine, natural medicine and nutriology:
people carrying toxoplasma gondii have fatigue and low immune function;
people with serious infection and human bodies have cough, fever, dizziness, headache and abdominal pain.
II, bringing into clinic:
all the above symptoms can be clinically treated.
Thirdly, taking method and dosage:
the administration method comprises the following steps: can be taken orally or chewed
Taking: twice daily: one in the morning and evening, 1000-2000 mg each time (1-2 tablets)
Fourthly, efficacy standard:
the method has the following advantages: the infection symptom is improved after taking a course of treatment.
The effect is shown: after taking the medicine for two courses of treatment, the infection symptoms are obviously improved.
And (3) healing: after taking for 2-3 courses of treatment, the joint is powerful, the immunity is enhanced, and the fatigue is resisted.
And (4) invalidation: taking for 1-2 treatment courses, and no symptom relief or improvement.
Fifth, statistics of clinical results:
the infected person: 12 persons; slight discomfort; wherein: cure 9 patients and show 3 patients.
31 severely infected persons; cough, fever, dizziness, headache, abdominal pain: 16 persons; after 3 courses of treatment, 12 patients can be cured, and 4 patients can be treated obviously.
Cough: 11 persons; after 3 courses of treatment, 5 patients are cured, and 6 patients are treated.
Fever is caused: 4 persons; all healed in 3 courses of treatment and can move freely.
Clinical statistics were as follows: the effective rate is as follows: 100 parts by weight; the display efficiency is as follows: 30 parts by weight; the cure rate is as follows: 70 parts by weight; inefficiency: and no display.
The invention is utilized to carry out experiments on animals infected with toxoplasma gondii, and the measured comparative data further proves that the medicinal and edible five-essence tablet candy has special efficacy and function.
The following list of typical cases further demonstrates the efficacy of the present invention:
medical record 1: male, 49 years old
The main points are as follows: dizziness, headache, and weakness of feet, and people feel well tired when feeling dry, and the people who see the hospital have a little time to eat more and better, strengthen nutrition and do not check out any problem.
Physical examination: blood staining test, detection of lgg antibody, indirect hemagglutination test: the following are found: infection with Toxoplasma gondii.
Treatment: after taking the product of the invention in the example 1, the examination was repeated 40 days after 1 tablet (1000mg) in the morning and 2 tablets (2000mg) in the evening (before sleeping).
And (4) rechecking after 40 days: no dizziness and headache, powerful walking, full spirit, blood staining test, lgg antibody detection, indirect blood coagulation test, recovery and recovery.
Medical record 2: a woman, age 53
The main complaints are: cough and abdominal pain often occur, and no disease can be detected in hospitals.
Physical examination: blood staining test, detection of lgg antibody, indirect hemagglutination test. Diagnosis: toxoplasma gondii infection.
Treatment: after taking the product of the invention in the example 2, 1 tablet (1000mg) in the morning and 2 tablets (2000mg) before sleeping at night, the examination is repeated after two months.
After 3 treatment courses, reexamination is carried out:
cough and abdominal pain are completely improved, walking is forceful, and the patient can be cured after taking the medicine for 2 courses.
And (4) proposing: the dosage for health promotion is 1 tablet in the morning and evening respectively.
Medical record 3: 65 years old for a male
The main complaints are: frequent dizziness and headache are caused, and when a doctor visits a hospital, the disease is a blood disease, the patient takes the medicine for three years, and the medicine is old and easy to have fever and hypodynamia.
Physical examination: blood staining test, detection of lgg antibody, indirect hemagglutination test.
Diagnosis: severe toxoplasma infection.
Treatment: after taking the product of the invention in example 3, 2 tablets (1000mg X2) are taken in the morning and 2 tablets (1000mg X2) are taken before the night sleep for 80 days
And (4 treatment courses).
And (4) rechecking: the toxoplasma gondii infection is absent and basically normal.
Fever, dizziness and headache are completely relieved.
The patients are recovered after 5 courses of treatment and follow-up service.
The tablet for inhibiting and expelling toxoplasma gondii and toxoplasma gondii capsule bodies, which is continuously used by the invention, can effectively inhibit the propagation activity of the toxoplasma gondii, thereby killing the toxoplasma gondii in a human body, preventing the toxoplasma gondii from propagating in the human body, preventing the infection between people and reducing the diseases brought by the toxoplasma gondii.
The above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.
Claims (3)
1. The medicinal and edible five-essence tabletted candy for expelling toxoplasma gondii is characterized by being prepared from the following raw materials in parts by weight: 30-40 parts of fructo-oligosaccharide, 18-20 parts of rhizoma polygonati, 3-5 parts of ginseng, 10-12 parts of boxthorn leaves, 6-8 parts of Chinese yam, 3-5 parts of dendrobe, 3-5 parts of honeysuckle, 3-5 parts of dandelion, 3-5 parts of liquorice, 3-5 parts of purslane, 3-5 parts of black garlic, 3-5 parts of angelica dahurica and 3-5 parts of platycodon grandiflorum.
2. The medicinal and edible five-essential tabletted candy for expelling toxoplasma according to claim 1, which is characterized by being prepared from the following raw materials in parts by weight: 31 parts of fructo-oligosaccharide, 19 parts of rhizoma polygonati, 4 parts of ginseng, 11 parts of boxthorn leaves, 7 parts of Chinese yam, 4 parts of dendrobium, 4 parts of honeysuckle, 4 parts of dandelion, 4 parts of liquorice, 4 parts of purslane, 4 parts of black garlic, 4 parts of angelica dahurica and 4 parts of platycodon grandiflorum.
3. A preparation method of medicinal and edible five-essence tabletted candy for expelling toxoplasma gondii is characterized by comprising the following steps:
step S1: selecting raw materials, namely selecting rhizoma polygonati, ginseng, boxthorn leaves, Chinese yam, dendrobium, honeysuckle, dandelion, liquorice, purslane, black garlic, angelica dahurica and platycodon grandiflorum for preparing the five-essence tablet candy; wherein rhizoma Polygonati, Lycii folium, rhizoma Dioscoreae, herba Dendrobii, flos Lonicerae, herba Taraxaci, Glycyrrhrizae radix, herba Portulacae, black Bulbus Allii, radix Angelicae Dahuricae, and radix Platycodi are all refined decoction pieces which are produced in the same year, and processed strictly according to decoction piece standard, and Ginseng radix is artificially planted for more than five years;
step S2: ultrasonic cell wall breaking, ultrasonic cell crusher utilizes the dispersion effect of ultrasonic wave in liquid, makes liquid produce the effect of cavitation to make solid particle or cell tissue in the liquid break. Putting the cleaned Chinese medicinal herb refined decoction pieces into an ultrasonic cell pulverizer with power of 40KHZ of 1200W, and adding water 2; breaking cell wall at 40 deg.C for 4 min according to the proportion of medicine 1;
step S3: supercritical extraction, namely putting the raw materials prepared in the step S2 into SEF production equipment, taking CO2 as an extracting agent, producing the raw materials in an environment at the temperature lower than 25 ℃, fully dissolving the traditional Chinese medicinal materials by utilizing the relation between the dissolving capacity and the density of a supercritical fluid, and controlling the pressure range to obtain a mixed solution with the optimal proportion; then, the extracted substances are completely or basically precipitated by methods such as decompression and the like, impurities and ineffective components are removed in the process, and a high-concentration mixed solution is generated;
step S4: granulating, namely boiling and granulating the high-concentration mixed solution obtained in the step S3 by using fructo-oligosaccharide as a base material;
step S5: and (6) tabletting and forming.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210287626.XA CN114617936A (en) | 2022-03-23 | 2022-03-23 | Medicinal and edible five-refined-pressure-tablet candy capable of expelling toxoplasma gondii and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210287626.XA CN114617936A (en) | 2022-03-23 | 2022-03-23 | Medicinal and edible five-refined-pressure-tablet candy capable of expelling toxoplasma gondii and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114617936A true CN114617936A (en) | 2022-06-14 |
Family
ID=81903577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210287626.XA Pending CN114617936A (en) | 2022-03-23 | 2022-03-23 | Medicinal and edible five-refined-pressure-tablet candy capable of expelling toxoplasma gondii and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114617936A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108498699A (en) * | 2018-06-20 | 2018-09-07 | 北京刚地源弓形虫病医学研究院 | A kind of formula wine and preparation method thereof for driving away toxoplasma |
CN108902968A (en) * | 2018-06-20 | 2018-11-30 | 北京刚地源弓形虫病医学研究院 | A kind of integration of drinking and medicinal herbs food addition formula and preparation method thereof for driving away toxoplasma |
CN109646571A (en) * | 2017-10-12 | 2019-04-19 | 王广民 | Public English gold oral solution and preparation method thereof |
-
2022
- 2022-03-23 CN CN202210287626.XA patent/CN114617936A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109646571A (en) * | 2017-10-12 | 2019-04-19 | 王广民 | Public English gold oral solution and preparation method thereof |
CN108498699A (en) * | 2018-06-20 | 2018-09-07 | 北京刚地源弓形虫病医学研究院 | A kind of formula wine and preparation method thereof for driving away toxoplasma |
CN108902968A (en) * | 2018-06-20 | 2018-11-30 | 北京刚地源弓形虫病医学研究院 | A kind of integration of drinking and medicinal herbs food addition formula and preparation method thereof for driving away toxoplasma |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105250723A (en) | Medicine for treating diabetes | |
CN102614486B (en) | Traditional Chinese medical liquor for treatment of deficiency of liver-yin and kidney-yin | |
CN104069474A (en) | Traditional Chinese medicine composition for treating seborrheic alopecia and preparation method thereof | |
CN107432881A (en) | A kind of Chinese medicine composition, preparation method and its application in terms of improving and treating male's sexual | |
CN102988701A (en) | Chinese medicament for treating constipation and preparation process thereof | |
CN106994141B (en) | Traditional Chinese medicine composition for treating constipation and preparation method thereof | |
CN103816454A (en) | Pure traditional Chinese medicine capsule for treating arteriosclerosis | |
CN114588230A (en) | Medicinal and edible food for blocking toxoplasma infection and arousing human immunity | |
CN105616655A (en) | Medicinal and edible composition applicable to stagnant blood constitution | |
CN105148220A (en) | Traditional Chinese medicine for treating spleen-kidney yang deficiency type dizziness and preparation method of traditional Chinese medicine | |
CN104857210A (en) | Traditional Chinese medicine combination preparation for treating fatty liver and preparation method thereof | |
CN113575944A (en) | Food additive with efficacy of expelling toxoplasma gondii and preparation method and application thereof | |
CN107998366A (en) | It is a kind of suitable for Chinese medicine composition of puerpera's lactagogue at initial stage in postpartum and preparation method thereof | |
CN103301341A (en) | Traditional Chinese medicine composition of treating ischemic cerebral apoplexy | |
CN103611005B (en) | Medicine for treating chronic pharyngitis and preparation method thereof | |
CN114617936A (en) | Medicinal and edible five-refined-pressure-tablet candy capable of expelling toxoplasma gondii and preparation method thereof | |
CN106039174A (en) | Traditional Chinese medicinal liquor for treating osteoarthrosis | |
CN104840686A (en) | Blood-pressure reduction type health-care tea | |
CN103977279A (en) | Traditional Chinese medicine additive for treating sow hysteritis and preparation method thereof | |
CN102579872A (en) | Medical composition with weight reducing function | |
CN106359737A (en) | Honey black tea and making method thereof | |
CN105362669A (en) | Controlled-release tablet for treating epidemic hemorrhagic fever and preparation method thereof | |
CN104887980A (en) | Traditional Chinese medicine compound, preparation thereof and preparation method and application of preparation | |
CN105288212A (en) | Traditional Chinese medicine composition for treating yin deficiency fire excess type insomnia and preparing method thereof | |
CN105434987A (en) | Traditional Chinese medicine preparation for treating cerebral infarction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |